These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 14962403)

  • 41. [The concept of working memory in schizophrenia: current evidence and future perspectives].
    Wolf RC; Vasic N; Walter H
    Fortschr Neurol Psychiatr; 2006 Aug; 74(8):449-68. PubMed ID: 16586253
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Working memory related gamma oscillations in schizophrenia patients.
    Basar-Eroglu C; Brand A; Hildebrandt H; Karolina Kedzior K; Mathes B; Schmiedt C
    Int J Psychophysiol; 2007 Apr; 64(1):39-45. PubMed ID: 16962192
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Age-related changes in antisaccade task performance: inhibitory control or working-memory engagement?
    Eenshuistra RM; Ridderinkhof KR; van der Molen MW
    Brain Cogn; 2004 Nov; 56(2):177-88. PubMed ID: 15518934
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Inhibition errors in borderline personality disorder with psychotic-like symptoms.
    Grootens KP; van Luijtelaar G; Buitelaar JK; van der Laan A; Hummelen JW; Verkes RJ
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Jan; 32(1):267-73. PubMed ID: 17889419
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Saccade generation and suppression in schizophrenia: effects of response switching and perseveration.
    Franke C; Arndt D; Ploner CJ; Heinz A; Reuter B
    Psychophysiology; 2008 Sep; 45(5):698-704. PubMed ID: 18513361
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Working memory and the psychopathology of schizophrenia].
    Walter H; Wolf RC
    Fortschr Neurol Psychiatr; 2008 May; 76 Suppl 1():S16-23. PubMed ID: 18461540
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Genetically predisposed offspring with schizotypal features: an ultra high-risk group for schizophrenia?
    Diwadkar VA; Montrose DM; Dworakowski D; Sweeney JA; Keshavan MS
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Mar; 30(2):230-8. PubMed ID: 16318899
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
    Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
    Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Antisaccade performance is related to genetic loading for schizophrenia.
    Petrovsky N; Weiss-Motz F; Schulze-Rauschenbach S; Lemke M; Hornung P; Ruhrmann S; Klosterkötter J; Maier W; Ettinger U; Wagner M
    J Psychiatr Res; 2009 Jan; 43(3):291-7. PubMed ID: 18585739
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Developmental changes in oculomotor control and working-memory efficiency.
    Eenshuistra RM; Ridderinkhof KR; Weidema MA; van der Molen MW
    Acta Psychol (Amst); 2007 Jan; 124(1):139-58. PubMed ID: 17113020
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Event-related theta oscillations during working memory tasks in patients with schizophrenia and healthy controls.
    Schmiedt C; Brand A; Hildebrandt H; Basar-Eroglu C
    Brain Res Cogn Brain Res; 2005 Dec; 25(3):936-47. PubMed ID: 16289526
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Antisaccade deficit after inactivation of the principal sulcus in monkeys.
    Condy C; Wattiez N; Rivaud-Péchoux S; Tremblay L; Gaymard B
    Cereb Cortex; 2007 Jan; 17(1):221-9. PubMed ID: 16481562
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The prefrontal substrate of reflexive saccade inhibition in humans.
    Ploner CJ; Gaymard BM; Rivaud-Péchoux S; Pierrot-Deseilligny C
    Biol Psychiatry; 2005 May; 57(10):1159-65. PubMed ID: 15866556
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Relationship of affect recognition with psychopathology and cognitive performance in schizophrenia.
    Bozikas VP; Kosmidis MH; Anezoulaki D; Giannakou M; Karavatos A
    J Int Neuropsychol Soc; 2004 Jul; 10(4):549-58. PubMed ID: 15327733
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Neuropsychological and clinical correlates of antisaccade task performance in schizophrenia.
    Nieman DH; Bour LJ; Linszen DH; Goede J; Koelman JH; Gersons BP; Ongerboer de Visser BW
    Neurology; 2000 Feb; 54(4):866-71. PubMed ID: 10690978
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Brain activation during executive processes in schizophrenia.
    Royer A; Schneider FC; Grosselin A; Pellet J; Barral FG; Laurent B; Brouillet D; Lang F
    Psychiatry Res; 2009 Sep; 173(3):170-6. PubMed ID: 19643585
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Learning potential and cognitive remediation in schizophrenia].
    Raffard S; Gely-Nargeot MC; Capdevielle D; Bayard S; Boulenger JP
    Encephale; 2009 Sep; 35(4):353-60. PubMed ID: 19748372
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Working memory functioning in schizophrenia patients and their first-degree relatives: cognitive functioning shedding light on etiology.
    Conklin HM; Curtis CE; Calkins ME; Iacono WG
    Neuropsychologia; 2005; 43(6):930-42. PubMed ID: 15716163
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Treatment of cognitive dysfunction in schizophrenia.
    Peuskens J; Demily C; Thibaut F
    Clin Ther; 2005; 27 Suppl A():S25-37. PubMed ID: 16198199
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Mismatch negativity deficits are associated with poor functioning in schizophrenia patients.
    Light GA; Braff DL
    Arch Gen Psychiatry; 2005 Feb; 62(2):127-36. PubMed ID: 15699289
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.